4//SEC Filing
GOWER BOB G 4
Accession 0001493152-23-003343
CIK 0001716947other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:06 PM ET
Size
7.9 KB
Accession
0001493152-23-003343
Insider Transaction Report
Form 4
GOWER BOB G
Director10% Owner
Transactions
- Purchase
Common Stock
2022-12-09$1.40/sh+357,143$500,000→ 753,095 total - Award
Warrants
2022-12-09+714,286→ 716,365 totalExercise: $1.40Exp: 2027-12-09→ Common Stock (714,286 underlying)
Footnotes (3)
- [F1]On October 28, 2022, Ensysce Biosciences, Inc. (the "Company"), pursuant to an amendment to the Company's Third Amended and Restated Certificate of Incorporation, effectuated a one-for-twenty reverse stock split of the Company's common stock, par value $0.0001 (the "Common Stock").
- [F2]On December 9, 2022, Mr. Gower purchased 357,143 shares of Common Stock at a price of $1.40 per share.
- [F3]On December 9, 2022, Mr. Gower purchased 357,143 warrants to purchase 714,286 shares of Common Stock with an exercise price of $1.40 per share (the "Warrants") in an underwritten offering further described on the Company's Prospectus filed pursuant to Rule 424(b)(4) (File No. 333-268038) filed with the Commission on December 9, 2022. The Warrants are immediately exercisable and may be exercised until five years from the date of issuance.
Documents
Issuer
Ensysce Biosciences, Inc.
CIK 0001716947
Entity typeother
Related Parties
1- filerCIK 0001136466
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 6:06 PM ET
- Size
- 7.9 KB